Time to fibrinolytics for acute myocardial infarction : reasons for delays at Steve Biko Academic Hospital, Pretoria, South Africa

Show simple item record

dc.contributor.author Meel, R.
dc.contributor.author Goncalves, R.
dc.date.accessioned 2016-05-11T11:52:18Z
dc.date.available 2016-05-11T11:52:18Z
dc.date.issued 2016-01
dc.description.abstract BACKGROUND. Fibrinolytic therapy is a time-critical intervention proven to reduce mortality and morbidity in patients with ST-elevation myocardial infarction (STEMI). Limited data exist in South Africa (SA) regarding time to fibrinolytic therapy for STEMI patients and reasons for delayed therapy. OBJECTIVES. To establish the proportion of STEMI patients receiving fibrinolytic agents at Steve Biko Academic Hospital (SBAH), Pretoria, SA, identify any delays to receiving fibrinolytic agents, and uncover reasons for those delays. The number of lives lost as a result of these delays was calculated. METHODS. This prospective, observational study included 100 consecutive patients presenting with a STEMI to SBAH. Using a researcheradministered questionnaire, the times from symptom onset to receipt of fibrinolytic therapy and the reasons for delays were documented. The number of lives lost was then calculated. RESULTS. Only 37% of patients received fibrinolytic therapy and only 3% received the medication within 1 hour. The median total delay in receiving fibrinolytic therapy was 270 minutes (range 45 - 584). The median time delays from onset of symptoms to call for help, between calling for help and arriving at hospital, and from hospital arrival to fibrinolytic agent administration, were 35 minutes (5 - 1 185), 55 minutes (12.5 - 670) and 62.5 minutes (16.5 - 282), respectively. Numerous delays were identified at all stages, with patient and transport delays being most significant. Strikingly, an additional 32 patients per 1 000 treated could have been saved if a fibrinolytic agent had been administered within 1 hour. CONCLUSIONS. This study highlights the important problem of delayed or non-administration of fibrinolytic therapy at a tertiary hospital. The problems identified will contribute to the implementation of a robust STEMI management network in SA, similar to those in developed countries. en_ZA
dc.description.department Internal Medicine en_ZA
dc.description.librarian am2016 en_ZA
dc.description.uri http://www.samj.org.za en_ZA
dc.identifier.citation Meel, R & Goncalves, R 2016, 'Time to fibrinolytics for acute myocardial infarction : reasons for delays at Steve Biko Academic Hospital, Pretoria, South Africa', South African Medical Journal, vol. 106, no. 1, pp. 92-96. en_ZA
dc.identifier.issn 0256-9574 (print)
dc.identifier.issn 2078-5135 (online)
dc.identifier.other 10.7196/SAMJ.2016.v106i1.9801
dc.identifier.uri http://hdl.handle.net/2263/52564
dc.language.iso en en_ZA
dc.publisher Health and Medical Publishing Group en_ZA
dc.rights © 2016 Health & Medical Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial Works License (CC BY-NC 3.0). en_ZA
dc.subject Fibrinolytic therapy en_ZA
dc.subject Patients en_ZA
dc.subject ST-Elevation myocardial infarction (STEMI) en_ZA
dc.subject South Africa (SA) en_ZA
dc.title Time to fibrinolytics for acute myocardial infarction : reasons for delays at Steve Biko Academic Hospital, Pretoria, South Africa en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record